Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MO

Uncovering Key Insights on Altria – A Comprehensive Overview

One of the losers of today's trading session was Altria. Shares of the Tobacco company plunged -4.0%, and some investors may be wondering if its price of $56.44 would make a good entry point. Here's what you should know if you are considering this investment:

  • Altria has moved 39.6% over the last year, and the S&P 500 logged a change of 8.1%

  • MO has an average analyst rating of hold and is -0.84% away from its mean target price of $56.92 per share

  • Its trailing earnings per share (EPS) is $6.54

  • Altria has a trailing 12 month Price to Earnings (P/E) ratio of 8.6 while the S&P 500 average is 29.3

  • Its forward earnings per share (EPS) is $5.35 and its forward P/E ratio is 10.5

  • Altria is part of the Consumer Defensive sector, which has an average P/E ratio of 23.09 and an average P/B of 3.3

  • MO has reported YOY quarterly earnings growth of 53.9% and gross profit margins of 0.7%

  • The company has a free cash flow of $4.63 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS